RxDoctor Payments Data

Ali Mesiwala, MD

Neurological Surgery · Rancho Cucamonga, CANPI 1306814868

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $1,145,120 of the $1,499,674 with a category attached, or 76.4%. Si-bone, Inc. accounts for 67.2% of it on its own, with 41 other manufacturers making up the rest. 2025 is the largest year on record at $588,116, 4.6 times the $128,213 reported in 2019. Among neurological surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,499,674in general payments, 2019–2025

Across 841 payments — averaging $1783.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Si-bone, Inc.$1M
  • Life Spine, Inc.$211K
  • Neo Spine USA, Inc.$128K
  • Globus Medical$64K
  • Abbott$43K
  • Vy Spine LLC$19K
  • plus $27K from 36 others
$214,432in research payments, 2019–2025

Across 14 payments — averaging $15,317 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Orthofix Medical, Inc.$203K
  • Si-bone, Inc.$6K
  • Globus Medical$5K
$12,500in ownership & investment interests, 2019–2025

Across 8 payments — averaging $1562.50 each. An ownership or investment interest held by the physician or an immediate family member.

  • Spinal Surgical Strategies, Inc.$13K
  • Rhausler Inc.$0

What the payments were for

  • Royalty or licence$1,145,12076%
  • Consulting fees$296,96520%
  • Speaking & faculty fees$2,5160%
  • Travel & lodging$35,2722%
  • Food & beverage$18,8651%
  • Education$9370%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,499,674 in reported general payments places this provider in the 95th percentile of 773 neurological surgery providers in California.

See all neurological surgery providers in California

Medicare billing

Part B allowed, 2024
$237,377
Medicare patients
295
Services billed
790

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen45$897
Celecoxib22$721
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen16$331
Gabapentin19$287
Baclofen20$278
Methocarbamol12$254
Methylprednisolone17$103
Ondansetron Hcl14$69

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Rancho Cucamonga

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →